| Literature DB >> 26384355 |
Yunze Zhao1, Jie Zhou2, Dan Liu3, Fang Dong1, Hui Cheng1, Weili Wang1, Yakun Pang1, Yajie Wang1, Xiaohuan Mu1, Yanli Ni2, Zhuan Li2, Huiyu Xu2, Sha Hao1, Xiaochen Wang1, Shihui Ma1, Qian-fei Wang3, Guozhi Xiao4, Weiping Yuan1, Bing Liu5, Tao Cheng6.
Abstract
The fetal liver (FL) serves as a predominant site for expansion of functional hematopoietic stem cells (HSCs) during mouse embryogenesis. However, the mechanisms for HSC development in FL remain poorly understood. In this study, we demonstrate that deletion of activating transcription factor 4 (ATF4) significantly impaired hematopoietic development and reduced HSC self-renewal in FL. In contrast, generation of the first HSC population in the aorta-gonad-mesonephros region was not affected. The migration activity of ATF4(-/-) HSCs was moderately reduced. Interestingly, the HSC-supporting ability of both endothelial and stromal cells in FL was significantly compromised in the absence of ATF4. Gene profiling using RNA-seq revealed downregulated expression of a panel of cytokines in ATF4(-/-) stromal cells, including angiopoietin-like protein 3 (Angptl3) and vascular endothelial growth factor A (VEGFA). Addition of Angptl3, but not VEGFA, partially rescued the repopulating defect of ATF4(-/-) HSCs in the culture. Furthermore, chromatin immunoprecipitation assay in conjunction with silencing RNA-mediated silencing and complementary DNA overexpression showed transcriptional control of Angptl3 by ATF4. To summarize, ATF4 plays a pivotal role in functional expansion and repopulating efficiency of HSCs in developing FL, and it acts through upregulating transcription of cytokines such as Angptl3 in the microenvironment.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26384355 PMCID: PMC4653766 DOI: 10.1182/blood-2015-03-633354
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113